Medicare's new MFN drug pricing plan could save $11.6 billion by anchoring US prices to foreign benchmarks, but side deals and lawsuits may erase most gains.
Medicare's new MFN drug pricing plan could save $11.6 billion by anchoring US prices to foreign benchmarks, but side deals and lawsuits may erase most gains.
Share this Article
Recommended